BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18242011)

  • 21. Retinoic acid receptor beta2 is epigenetically silenced either by DNA methylation or repressive histone modifications at the promoter in cervical cancer cells.
    Zhang Z; Joh K; Yatsuki H; Zhao W; Soejima H; Higashimoto K; Noguchi M; Yokoyama M; Iwasaka T; Mukai T
    Cancer Lett; 2007 Mar; 247(2):318-27. PubMed ID: 16806674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel relationships among DNA methylation, histone modifications and gene expression in Ascobolus.
    Barra JL; Holmes AM; Grégoire A; Rossignol JL; Faugeron G
    Mol Microbiol; 2005 Jul; 57(1):180-95. PubMed ID: 15948959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A site to remember: H3K36 methylation a mark for histone deacetylation.
    Lee JS; Shilatifard A
    Mutat Res; 2007 May; 618(1-2):130-4. PubMed ID: 17346757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Friedreich ataxia GAA repeat expansion mutation induces comparable epigenetic changes in human and transgenic mouse brain and heart tissues.
    Al-Mahdawi S; Pinto RM; Ismail O; Varshney D; Lymperi S; Sandi C; Trabzuni D; Pook M
    Hum Mol Genet; 2008 Mar; 17(5):735-46. PubMed ID: 18045775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epigenetic regulation of cytomegalovirus major immediate-early promoter activity in transgenic mice.
    Mehta AK; Majumdar SS; Alam P; Gulati N; Brahmachari V
    Gene; 2009 Jan; 428(1-2):20-4. PubMed ID: 18976699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myc-binding-site recognition in the human genome is determined by chromatin context.
    Guccione E; Martinato F; Finocchiaro G; Luzi L; Tizzoni L; Dall' Olio V; Zardo G; Nervi C; Bernard L; Amati B
    Nat Cell Biol; 2006 Jul; 8(7):764-70. PubMed ID: 16767079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired recruitment of the histone methyltransferase DOT1L contributes to the incomplete reactivation of tumor suppressor genes upon DNA demethylation.
    Jacinto FV; Ballestar E; Esteller M
    Oncogene; 2009 Nov; 28(47):4212-24. PubMed ID: 19734945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic regulation of microRNAs in acute lymphoblastic leukemia.
    Roman-Gomez J; Agirre X; Jiménez-Velasco A; Arqueros V; Vilas-Zornoza A; Rodriguez-Otero P; Martin-Subero I; Garate L; Cordeu L; San José-Eneriz E; Martin V; Castillejo JA; Bandrés E; Calasanz MJ; Siebert R; Heiniger A; Torres A; Prosper F
    J Clin Oncol; 2009 Mar; 27(8):1316-22. PubMed ID: 19164206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentially expressed genes are marked by histone 3 lysine 9 trimethylation in human cancer cells.
    Wiencke JK; Zheng S; Morrison Z; Yeh RF
    Oncogene; 2008 Apr; 27(17):2412-21. PubMed ID: 17968314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leaving a mark: the many footprints of the elongating RNA polymerase II.
    Eissenberg JC; Shilatifard A
    Curr Opin Genet Dev; 2006 Apr; 16(2):184-90. PubMed ID: 16503129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crucial role of antisense transcription across the Xist promoter in Tsix-mediated Xist chromatin modification.
    Ohhata T; Hoki Y; Sasaki H; Sado T
    Development; 2008 Jan; 135(2):227-35. PubMed ID: 18057104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of transcriptional repression by histone lysine methylation.
    Hublitz P; Albert M; Peters AH
    Int J Dev Biol; 2009; 53(2-3):335-54. PubMed ID: 19412890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. H2B-K123 ubiquitination stimulates RNAPII elongation independent of H3-K4 methylation.
    Shukla A; Bhaumik SR
    Biochem Biophys Res Commun; 2007 Jul; 359(2):214-20. PubMed ID: 17543890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histone modifications defining active genes persist after transcriptional and mitotic inactivation.
    Kouskouti A; Talianidis I
    EMBO J; 2005 Jan; 24(2):347-57. PubMed ID: 15616580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chromatin changes on the GSTP1 promoter associated with its inactivation in prostate cancer.
    Okino ST; Pookot D; Majid S; Zhao H; Li LC; Place RF; Dahiya R
    Mol Carcinog; 2007 Oct; 46(10):839-46. PubMed ID: 17415778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Small interfering RNA (siRNA) targeting of endogenous promoters induces DNA methylation, but not necessarily gene silencing, in rice.
    Okano Y; Miki D; Shimamoto K
    Plant J; 2008 Jan; 53(1):65-77. PubMed ID: 17971040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcription outcome of promoters enriched in histone variant H3.3 defined by positioning of H3.3 and local chromatin marks.
    Lund EG; Collas P; Delbarre E
    Biochem Biophys Res Commun; 2015 May; 460(2):348-53. PubMed ID: 25783056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Control of human cytomegalovirus gene expression by differential histone modifications during lytic and latent infection of a monocytic cell line.
    Ioudinkova E; Arcangeletti MC; Rynditch A; De Conto F; Motta F; Covan S; Pinardi F; Razin SV; Chezzi C
    Gene; 2006 Dec; 384():120-8. PubMed ID: 16989963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different epigenetic layers engage in complex crosstalk to define the epigenetic state of mammalian rRNA genes.
    Grummt I
    Hum Mol Genet; 2007 Apr; 16 Spec No 1():R21-7. PubMed ID: 17613545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of lymphocyte-specific inactivation of RAG-2 intragenic promoter of NWC: implications for epigenetic control of RAG locus.
    Cebrat M; Cebula A; Laszkiewicz A; Kasztura M; Miazek A; Kisielow P
    Mol Immunol; 2008 Apr; 45(8):2297-306. PubMed ID: 18166226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.